NIOX.LSE NIOX Group PLC

Healthcare Health Care Equipment & Supplies London Exchange
0.6440 GBX
Close of Nov 3, 2026
52.49 80.00
Market cap
GBX 261M
P/E
32.2x
P/B
4.08x
ROE
35.7%
Dividend yield
2.33%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is NIOX.LSE undervalued?

Graham number
Price0.6440
Graham value0.2664
Premium141.7%

NIOX.LSE trades 141.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NIOX Group PLC fundamental analysis

No fundamental analysis for NIOX Group PLC yet.

NIOX Group PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NIOX Group PLC

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc …

Full company profile